[1] Germani G,Hytiroglou P,Fotiadu A, et al. Assessment of fibrosis and cirrhosis in liver biopsies: an update. Semin Liver Dis, 2011,31: 82-90.
[2] 张英男,徐文贵,王成,等. 核素动态显象肝动脉和门静脉血流量测定评价肝硬化肝血流异常的应用. 白求恩医科大学学报, 1995,21: 638-640.
[3] O'Connor MK,MacMathuna P,Keeling PW. Hepatic arterial and portal venous components of liver blood flow: a dynamic scintigraphic study. J Nucl Med, 1988,29:466-472.
[4] 管昌田,张金谷. 闪烁显像评价肝血流动力学的方法及意义. 国外医学(放射医学核医学分册), 1991,15:176-181.
[5] 向荣成,章宏,顾竹影,等. 肝硬化患者门脉血流指数对Child-Pugh分级的意义. 中华核医学杂志, 1996,16:269.
[6] Sarper R,Fajman WA,Rypins EB,et al. A noninvasive method for measuring portal venous/total hepatic blood flow by hepatosplenic radionuclide angiography. Radiology, 1981,141:179-184.
[7] 王宝恩. 肝纤维化的诊断与严重度评估. 中华肝脏病杂志, 1998,6:193-194.
[8] 贾继东,尹珊珊. 肝纤维化的诊断和治疗进展. 临床内科杂志, 2002,19:244-247.
[9] 张军,朱阳军,李林法,等. 联合血清纤维化指标与门静脉灌注指数评估慢性乙型肝炎及肝硬化患者病情.中华传染病杂志,2012,30:374-377.
[10] 郑敏,蔡卫民,翁红雷,等. ROC曲线评价血清纤维化指标对诊断肝纤维化的价值. 中华传染病杂志, 2002,20:225-228.
[11] 陶嵘,沈江帆,王雁程,等. 放射性核素肝灌注显像在肝硬化中的应用. 中华核医学杂志, 1998,18:182.
[12] El-Khalily H,Hoeffken H,von Wichert p, et al. Hepatic perfusion scintigraphy. Relationship of liver perfusion and ascites in patients with liver cirrhosis. Clin Nucl Med, 1996, 21:132-135.
[13] Biersack HJ,Torres J,Thelen M, et al. Determination of liver and spleen perfusion by quantitative sequential scintigraphy: results in normal subjects and in patients with portal hypertension. Clin Nucl Med, 1981,6: 218-220.
[14] 景爱平,王道民,田洪春,等. 核素肝血流灌注显像及肝外分流测定在中晚期肝癌非切除性治疗中的临床应用. 肝胆外科杂志, 1997,5:241-243.
[15] Stadalnik, RC,DeNardo SJ,Denardo GL, et al. Critical evaluation of hepatic scintiangiography for neoplastic tumors of the liver. J Nucl Med, 1975,16: 595-601.
[16] Leveson SH,Wiggins PA,Giles GR,et al. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg, 1985,72:128-130.
[17] Ballantyne KC,Charnley RM,Perkins AC,et al. Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nucl Med Commun, 1990,11:23-28.
[18] Martin-Comin J,Mora J,Figueras J, et al. Calculation of portal contribution to hepatic blood flow with 99mTc-microcolloids. A noninvasive method to diagnose liver graft rejection. J Nucl Med, 1988,29:1776-1780. |
